Aurobindo Pharma
Aurobindo Pharma Ltd is an Indian pharmaceutical manufacturing company engaged in the research, development, production, and commercialization of generic pharmaceuticals and active pharmaceutical ingredients. The company manufactures generic oral solids, sterile injectables, antiretrovirals, cardiovascular drugs, central nervous system treatments, and active ingredients across multiple therapeutic areas. Its commercial operations cover major regulated international healthcare markets including the United States, Europe, and emerging economies. Principal revenue is derived from direct commercial sales of finished generic formulations to hospital networks, retail pharmacy chains, and global healthcare distributors, alongside exports of active ingredients. Aurobindo Pharma is one of the largest generic pharmaceutical manufacturers in India, recognized for its extensive vertical manufacturing integration. Headquartered in Hyderabad, India, the company's common stock is publicly listed and traded on the National Stock Exchange of India and BSE under the ticker AUROPHARMA.
18 of the funds FundTelligence covers report a position in Aurobindo Pharma.
- Legal name
- Aurobindo Pharma Ltd.
- Sector
- Health Care
- Country
- India
- Funds holding it
- 18
Funds holding Aurobindo Pharma
- Sparinvest Ethical Emerging Markets Value — Sparinvest · 0.98 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.21 % (full portfolio disclosed, June 2026)
- SEB Emerging Marketsfond — SEB · 0.16 % (full portfolio disclosed, June 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.12 % (full portfolio disclosed, September 2026)
- SEB Asienfond ex Japan — SEB · 0.09 % (full portfolio disclosed, June 2026)
- Storebrand Emerging Markets — Storebrand · 0.06 % (full portfolio disclosed, October 2026)
- DNB Emerging Markets Index — DNB · 0.05 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.04 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 18 funds holding it.